Drug Discovery Digital 2020 - Connect - Learn - Discover

Dr Michael Dawson

Dr Michael Dawson
Dr Michael Dawson
Director
Mike Dawson Antimicrobial Research Consultancy Ltd.
Speaker

Profile of Dr Michael Dawson

Mike Dawson is a biochemist with over 35 years of drug discovery experience in big pharma and biotech. After 20 years in natural product research with GSK and legacy companies, Mike co-founded Novacta Biosystems. As CSO he led the Company’s C. difficile programme, taking the novel lantibiotic derivative, NVB302, into clinical evaluation. Subsequently as CEO of Cantab Anti-infectives, he led the Company’s polymyxin programme until its acquisition by Spero Therapeutics. Mike is now consulting and is also Head of Biology for Oxford Drug Design. He has authored over 60 papers and is an inventor on over 20 patents.
Email
Please login to send a Private Message

Hosted By
ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
www.myeventflo.com/2299
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2003-2020